Loading company…
Valthos develops AI-based systems for biodefense and public health security.
Founded in 2024 and based in New York, Valthos develops technology to detect and respond to biological threats. Its work addresses pathogen detection, vaccine development, and rapid response for government, military, public health, and emergency response organizations. In October 2025, it raised USD 30.00 mn in Seed funding from Founders Fund, Lux Capital, and OpenAI.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in